[1]
BAQI, M.A. et al. 2025. MOLECULAR DOCKING INSIGHTS INTO PROBIOTICS SAKACIN P AND SAKACIN A AS POTENTIAL INHIBITORS OF THE COX-2 PATHWAY FOR COLON CANCER THERAPY. International Journal of Applied Pharmaceutics. 17, 1 (Jan. 2025), 153–160. DOI:https://doi.org/10.22159/ijap.2025v17i1.52476.